RU2808846C1 - METHOD OF GENOTYPING rs8107914 (CT) POLYMORPHIC LOCUS OF C19orf53 GENE IN HUMANS BY REAL-TIME PCR USING ALLELE-SPECIFIC FLUORESCENT PROBES - Google Patents

Abstract

FIELD: biotechnology; molecular genetic diagnostics.

SUBSTANCE: invention can be used in medicine to determine the hereditary predisposition to the development of diseases associated with carriage of rs8107914 (C>T) polymorphic variant of C19orf53 gene. The following is proposed: a method of genotyping rs8107914 (C>T) polymorphic locus of C19orf53 gene in humans by real-time PCR using allele-specific fluorescent probes, involving PCR using specially selected primers: forward 5'-CGCCTTTAGCAACCATGTG-3' and reverse 5'-CCAGCTTGACTCTGGTTGTG-3', and probes with fluorophores: C-allele-specific fluorescently labeled probe 5'-(FAM) CCGGGAAAGAGTCTTTTCTCC(RTQ1)-3' and T-allele-specific fluorescently labeled probe 5'-(ROX)CCGGGAAAGAGTTTTTTCTCC(BHQ2)-3' in amplifier with fluorescence detection.

EFFECT: expanding the arsenal of methods of genotyping polymorphic variants of C19orf53 gene, obtaining a simple and accurate method.

1 cl, 1 dwg

Description

The technical field to which the invention relates.The invention relates to the field of biotechnology, molecular genetic diagnostics, in particular to the assessment of single nucleotide polymorphism rs8107914 (C>T) geneC19orf53molecular genetic research method.

State of the art. GeneC19orf53 (Gene ID: 28974) is located on chromosome 19p13.13. Single nucleotide polymorphism rs8107914, position chr19:13778631 (GRCh38.p14) https://www.ncbi.nlm.nih.gov/snp/rs8107914) is localized in the intron and is characterized by the C>G,T substitution. However, the G allele occurs with a frequency of <0.000001 in European populations and is also characterized by a low frequency (<0.00001) in other populations of the world, and therefore the C>T substitution is relevant for studies of multifactorial human diseases. Using a range of bioinformatics tools, it was established that this genetic variant has a high regulatory potential. According to GTEx Portal, rs8107914 affects expression levelsC19orf53in blood vessels, heart, brain tissue, colon, etc. [https://gtexportal.org/home/snp/rs8107914]. In addition, this SNP is associated with histone modifications in various organs and tissues [https://pubs.broadinstitute.org/mammals/haploreg/detail_v4.2.php?query=&id=rs8107914] and affects DNA binding to transcription factors. The high functional significance of this genetic variant creates a need to create a method for identifying the targeted polymorphic variant rs8107914 that is simple to implement, inexpensive and accessible to all researchers working in the field of genetic epidemiology. (C>T) geneC19orf53.

There is a known method for analyzing genetic variations in the human genome by sequencing amplified DNA sections [Mardis E. R. DNA sequencing technologies: 2006–2016 //Nature protocols. – 2017. – Vol. 12. – No. 2. – P. 213-218]. The disadvantages of the method are the high cost of equipment and reagents, which excludes the widespread implementation of the method in experimental studies, especially the study of multifactorial diseases that require large sample sizes to ensure high power of studies.

There is a known method for analyzing genetic variations in the human genome using matrix-assisted laser desorption ionization mass spectrometry (MALDI). The method involves transferring the DNA to be analyzed onto a substrate, where it crystallizes with a matrix. The crystallized analytes are then transferred and irradiated with a laser, causing desorption and ionization of the molecules in a vacuum chamber. Positively charged DNA ions are accelerated and migrate through a vacuum tube to a highly sensitive detector at different speeds depending on the mass of the ions, resulting in different times of flight. Using the time of flight of individual ionized DNA analytes, the system determines mass and displays a mass spectrum identifying various genetic targets [Li D. et al. MALDI-TOF mass spectrometry in clinical analysis and research //ACS Measurement Science Au. – 2022. – Vol. 2. – No. 5. – P. 385-404]. The disadvantages of the method are labor intensity, high cost of equipment, high cost of the experiment, and the presence of highly qualified personnel.

The commercial genotyping kit rs8107914 was selected for the prototype. (C/T)C19orf53(C__29287820_10, catalog 4351379) from ThermoFisher. However, genotyping using commercial kits is characterized by high cost, and information about the structure of primers and allele-specific probes necessary for PCR is closed to researchers, and therefore this technique cannot be reproduced with a standard set of equipment and reagents.

Thus, there is a real need to create a fast, inexpensive and easily reproducible method for identifying the rs8107914 polymorphism (C>T) geneC19orf53, with a structure of primers and allele-specific probes available to all researchers, which could be used as a “routine” genotyping method in any PCR laboratory.

Disclosure of the invention. The technical result of this invention is the development of an easy-to-use and economically feasible method for genotyping the single nucleotide polymorphism rs8107914 (C>T), localized at position chr19:13778631 (GRCh38.p14) geneC19orf53 (Gene ID: 28974) by real-time polymerase chain reaction using allele-specific signal probes containing FAM and ROX fluorophores.

The technical result is achieved by identifying allelic variants of rs8107914 (C>T) geneC19orf53 carried out using

forward primer rs8107914 5′-CGCCTTTAGCAACCATGTG-3′ (SEQ ID NO 1), reverse primer rs8107914 5′-CCAGCTTGACTCTGGTTGTG-3′ (SEQ ID NO 2),

rs8107914-C-allele-specific fluorescently labeled probe 5′-(FAM)CCGGGAAAGAGT C TTTTCTCC(RTQ1)-3′(SEQ ID NO 3),

rs8107914-T allele-specific fluorescently labeled probe 5′-(ROX) CCGGGAAAGAGT T TTTTCTCC(BHQ2)-3′ (SEQ ID NO 4).

The invention is explained by the following figure: discrimination of alleles according to the locus RS8107914 C19orf53 Gene during genotyping by the PCR method in the “Real Time” mode using allele-specific fluorescent probes according to RFU quantities (relative units of fluorescence) on the CFX96 amplifier: RS810 amplifiers: genotypes RS810 7914-s/s are shown by orange circles, rs8107914-C/T genotypes are shown as green triangles, rs8107914-T/T genotypes are shown as blue squares; The black diamond indicates the negative control.

Work on the design of oligonucleotides included several stages:

1) Using the open database Ensembl genome browser 109 [https://www.ensembl.org/index.html], a synvenge flanking the desired single nucleotide substitution [C/T] rs8107914 C19orf53 was selected, and then using the available online software Primer3web version 4.1.0 [https://primer3.ut.ee/] the sequence of oligonucleotides used to carry out the PCR reaction has been selected:

forward general primer 5′-CGCCTTTAGCAACCATGTG-3′ (SEQ ID NO 1),

reverse general primer 5′-CCAGCTTGACTCTGGTTGTG-3′ (SEQ ID NO 2).

The size of the C19orf53 gene fragment amplified during PCR is 155 nucleotide pairs:

(CGCCTTTAGCAACCATGTGCCCAGGGGACAGCTGGGCTTCTTACACCCTGGCC

CTGAGCCTGAGAGCCGGGAAAGAGT[C/T]TTTTTCTCCATTTAACCCCGGGTGAC

TCACTCCCTGGCCAGTCCTCACCCCTGGGGACACAACCAGAGTCAAAGCTGG).

2). For probe design, practical recommendations were used [Basu C. (ed.). PCR primer design. – New york: Humana Press, 2015]. Hydrolysis probes were used in the reaction. The probe sequence was selected so that it would anneal to the template between the forward and reverse primers. Each probe was equipped with a fluorophore and a fluorescence quencher whose absorption spectrum corresponded to the wavelengths of the fluorophore spectrum. To quench FAM fluorescence, we used the RTQ1 quencher; for ROX fluorescence quenching - BHQ2 quencher.

Based on the stated criteria and practical recommendations, probes with the following structure were selected:

rs8107914-C-allele-specific fluorescently labeled probe 5′-(FAM)CCGGGAAAGAGT C TTTTCTCC(RTQ1)-3′(SEQ ID NO 3),

rs8107914-T allele-specific fluorescently labeled probe 5′-(ROX) CCGGGAAAGAGT T TTTTCTCC(BHQ2)-3′ (SEQ ID NO 4).

3) The production of primers and probes was carried out at the service center of NPK Syntol, Moscow.

4) Using practical experiments, optimal conditions for genotyping were selected, which include the following steps: 50°C for 2 minutes, 95°C for 10 minutes, then 39 cycles [95°C for 10 seconds and 57.5° C for 1 minute].

5) The developed method was tested in the laboratory of genomic research on 200 DNA samples of healthy individuals in the biobank of the Research Institute of Genetic and Molecular Epidemiology of KSMU. Genotyping was carried out according to the RFU (relative fluorescence units) values of probes with fluorescent dyes. According to the results of genotyping rs8107914, 116 people (58%) turned out to be homozygous for the C allele (genotype C/C); 72 people (36%) were heterozygotes (C/T genotype), 12 people (6%) individuals were T/T homozygotes.

6) Validation of the method was carried out by mass spectrometric analysis on a genomic time-of-flight mass spectrometer MassArray analyzer 4 (Agena Bioscience). The results of both genotyping methods completely coincided (100% of genotypes). However, the patented method of genotyping the polymorphic locus rs8107914 (C>T) of the C19orf53 gene using real-time PCR using allele-specific probes allows to significantly (by 6 hours) reduce the time of analysis, and also reduces the cost of analysis (by 4-5 once).

Implementation of the invention.

The method is carried out as follows:

1. Isolation of DNA from peripheral venous blood. At the first stage, 0.5 ml of PBS was added to 0.5 ml of blood and centrifuged for 10 min at 12 thousand rpm. The supernatant was discarded, 1 ml of PBS was added and centrifuged again under the same conditions. The supernatant was discarded, 200 μl of TE buffer was added, pipetted until the precipitate dissolved, and then 10 μl of 1% sodium dodecyl sulfate SDS and 5 μl of proteinase K were sequentially added. The tubes were incubated in a thermostat at t=37°C for 12 hours. During the second stage Four successive centrifugations with phenol and chloroform were performed according to the protocol (10 min, 8 thousand rpm), after which the DNA was precipitated with an ice-cold solution of 95% ethyl alcohol and centrifuged for 10 min at 14.3 thousand rpm. After the alcohol had evaporated, the DNA was dissolved in 100 μl of deionized distilled water. The resulting DNA solution in water had a purity in the range A260/280=1.5-2.0 and an average concentration of about 180-200 ng/μl.

2. Preparation of DNA samples for genotyping. The quality of the isolated DNA was assessed by the degree of purity and concentration of the solution using a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA). All analyzed DNA samples were diluted with deionized water to a concentration of 15-20 ng/μl at A260/280=1.5-2.0.

3. Analysis of the rs8107914 (C>T) polymorphism of the C19orf53 gene using real-time polymerase chain reaction using allele-specific probes. For genotyping, two flanking primers were used, forward (SEQ ID NO 1) and reverse (SEQ ID NO 2), as well as allele-specific probes: C-allele-specific fluorescently labeled probe (SEQ ID NO 3), T-allele- specific fluorescently labeled probe (SEQ ID NO 4).

Real-time PCR was carried out in 25 ml of a reaction mixture containing 1.25 U of Hot Start Taq DNA polymerase (Biolabmix, Novosibirsk, Russia), 20 ng of DNA, 10 μM of each primer, 5 μM of each probe, 0.03 mM each dNTP, 2.5 mM MgCl2; 1xPCR buffer [67 mM Tris-HCl, pH 8.8, 16.6 mM (NH4)2SO4, 0.01% Tween-20]. The amplification reaction consisted of a heating step of 50°C for 2 minutes, 95°C for 10 minutes, then 39 cycles [95°C for 10 seconds and 57.5°C for 1 minute].

4. Genotyping. When performing PCR in a cycler with fluorescent detection (Bio-Rad CFX96 or similar cycler), genotyping is carried out according to RFU (relative fluorescence units) values. For rs8107914 (C>T) of the C19orf53 gene, the probe with the fluorescent dye FAM corresponds to the C allele, and the probe with the ROX dye corresponds to the T allele (Fig. 1). The figure shows a clear division of the samples into clusters, where the black diamond corresponds to the negative control, the cluster of orange circles corresponds to the probe with the fluorescent dye FAM and allows the identification of C/C homozygotes. The cluster of blue squares corresponds to the ROX dye probe and allows the identification of T/T homozygotes. The cluster of green triangles corresponds to the accumulation of fluorescence for both probes and allows the identification of C/T heterozygotes.

Summary.

Thus, an effective and inexpensive method has been developed for the rapid identification of the polymorphic variant rs8107914 (C>T) of the C19orf53 gene in humans using real-time PCR using allele-specific fluorescent probes, which can be used in medicine to determine hereditary predisposition to the development of diseases associated with carriage of C19orf53 gene polymorphisms, as well as for scientific purposes.

--->

<?xml version="1.0" encoding="UTF-8"?>

<!DOCTYPE ST26SequenceListing PUBLIC "-//WIPO//DTD Sequence Listing

1.3//EN" "ST26SequenceListing_V1_3.dtd">

<ST26SequenceListing dtdVersion="V1_3" fileName="Method

genotyping of the polymorphic locus rs8107914 (C T) of the C19orf53 gene in

human by real-time PCR using

allele-specific fluorescent probes.xml" softwareName="WIPO

Sequence" softwareVersion="2.3.0" productionDate="2023-10-09">

<ApplicantFileReference>1818</ApplicantFileReference>

<ApplicantName languageCode="ru">Federal state

budgetary educational institution of higher education

&quot;Kursk State Medical University&quot;

Ministry of Health of the Russian Federation,</ApplicantName>

<ApplicantNameLatin>Kursk State Medical

University</ApplicantNameLatin>

<InventionTitle languageCode="en">Genotyping method

polymorphic locus rs8107914 (C&gt;T) of the C19orf53 gene in humans

real-time PCR method using

allele-specific fluorescent probes</InventionTitle>

<SequenceTotalQuantity>4</SequenceTotalQuantity>

<SequenceData sequenceIDNumber="1">

<INSDSeq>

<INSDSeq_length>19</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..19</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q2">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>cgcctttagcaaccatgtg</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="2">

<INSDSeq>

<INSDSeq_length>20</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..20</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q4">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>ccagcttgactctggttgtg</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="3">

<INSDSeq>

<INSDSeq_length>21</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..21</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q6">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>ccgggaaagagtcttttctcc</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="4">

<INSDSeq>

<INSDSeq_length>21</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..21</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q8">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>ccgggaaagagttttttctcc</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

</ST26SequenceListing>

<---

Claims (1)

A method for genotyping the polymorphic locus rs8107914 (C>T) of the C19orf53 gene in humans using real-time PCR using allele-specific fluorescent probes, characterized in that the identification of allelic variants rs8107914 (C>T) of the C19orf53 gene is carried out using a forward primer rs8107914 5'-CGCCTTTAGCAACCATGTG-3' (SEQ ID NO 1), reverse primer rs8107914 5'-CCAGCTTGACTCTGGTTGTG-3' (SEQ ID NO 2), rs8107914-C-allele-specific fluorescently labeled probe 5'-(FAM)CCGGGAAAGAGT C TTTTCTCC(RTQ1)-3' (SEQ ID NO 3), rs8107914-T allele-specific fluorescently labeled probe 5'-(ROX) CCGGGAAAGAGT T TTTTCTCC(BHQ2)-3' (SEQ ID NO 4).